Cap analysis of gene expression (CAGE) in these seven myeloma cell lines showed that the activity of both A3B promoters was aberrantly upregulated compared to that in CD19+ cells from healthy individuals (Supplemental Fig. 2). The gene discussed is CD19; the disease is plasma cell myeloma.